Gene name - salvador
Cytological map position - 94D10
Function - signaling
Symbol - sav
FlyBase ID: FBgn0026180
Genetic map position -
Classification - WW domains and coiled-coil domain
Cellular location - presumably cytoplasmic
|Recent literature||Aerne, B. L., Gailite, I., Sims, D. and Tapon, N. (2015). Hippo stabilises its adaptor Salvador by antagonising the HECT ubiquitin ligase Herc4. PLoS One 10: e0131113. PubMed ID: 26125558
Signalling through the Hippo (Hpo) pathway involves a kinase cascade, which leads to the phosphorylation and inactivation of the pro-growth transcriptional co-activator Yorkie (Yki). Despite the identification of a large number of pathway members and modulators, understanding of the molecular events that lead to activation of Hpo and the downstream kinase Warts (Wts) remain incomplete. Recently, targeted degradation of several Hpo pathway components has been demonstrated as a means of regulating pathway activity. In particular, the stability of scaffold protein Salvador (Sav), which is believed to promote Hpo/Wts association, is crucially dependent on its binding partner Hpo. In a cell-based RNAi screen for ubiquitin regulators involved in Sav stability, this study identified the HECT domain protein Herc4 (HECT and RLD domain containing E3 ligase) as a Sav E3 ligase. Herc4 expression promotes Sav ubiquitylation and degradation, while Herc4 depletion stabilises Sav. Interestingly, Hpo reduces Sav/Herc4 interaction in a kinase-dependent manner. This suggests the existence of a positive feedback loop, where Hpo stabilises its own positive regulator by antagonising Herc4-mediated degradation of Sav.
|Cairns, L., Tran, T., Fowl, B. H., Patterson, A., Kim, Y. J., Bothner, B. and Kavran, J. M. (2018). Salvador has an extended SARAH domain that mediates binding to Hippo kinase. J Biol Chem. PubMed ID: 29519817
The Hippo pathway controls cell proliferation and differentiation through the precisely tuned activity of a core kinase cassette. The activity of Hippo kinase is modulated by interactions between its C-terminal coiled-coil, termed the SARAH domain, and the SARAH domains of either dRassF or Salvador. This study examined the molecular basis of SARAH domain mediated interactions and their influence on Hippo kinase activity. Focused was placed on Salvador, a positive effector of Hippo activity and the least well characterized SARAH domain-containing protein. The crystal structure was determined of a complex between Salvador and Hippo SARAH domains from Drosophila. This structure provided insight into the organization of the Salvador SARAH domain including a folded N-terminal extension that expands the binding interface with Hippo SARAH domain. This extension was found to improve the solubility of Salvador SARAH domain, enhances binding to Hippo, and is unique to Salvador. It is therefore suggested that the definition of the Salvador SARAH domain be expanded to include this extended region. The heterodimeric assembly observed in the crystal was confirmed by crosslinked mass spectrometry and provided a structural basis for the mutually exclusive interactions of Hippo with either dRassF or Salvador. Salvador influenced the kinase activity of Mst2, the mammalian Hippo homolog. In co-transfected HEK293T cells, human Salvador increased the levels of Mst2 autophosphorylation and Mst2-mediated phosphorylation of select substrates, whereas Salvador SARAH domain inhibited Mst2 autophosphorylation in vitro. These results suggest Salvador enhances the effects of Hippo kinase activity at multiple points in the Hippo pathway.
|Albert, E. A., Puretskaia, O. A., Terekhanova, N. V., Labudina, A. and Bokel, C. (2018). Direct control of somatic stem cell proliferation factors by the Drosophila testis stem cell niche. Development. PubMed ID: 30002131
Niches have traditionally been characterized as signalling microenvironments that allow stem cells to maintain their fate. This definition implicitly assumes that the various niche signals are integrated towards a binary fate decision between stemness and differentiation. However, observations in multiple systems have demonstrated that stem cell properties such as proliferation and self renewal can be uncoupled at the level of niche signalling input, which is incompatible with this simplified view. This study has examined the role of the transcriptional regulator Zfh1, a shared target of the Hedgehog and Jak/Stat niche signalling pathways, in the somatic stem cells of the Drosophila testis. It was found that Zfh1 binds and downregulates salvador and kibra, two tumour suppressor genes of the Hippo/Wts/Yki pathway, thereby restricting Yki activation and proliferation to the Zfh1 positive stem cells. These observations provide an unbroken link from niche signal input to an individual aspect of stem cell behaviour that does not, at any step, involve a fate decision. The relevance of these findings is discussed for an overall concept of stemness and niche function.
So far, relatively few mechanisms have been shown to be capable of regulating both cell proliferation and cell death in a coordinated manner. In a screen for Drosophila mutations that result in tissue overgrowth, the gene salvador (sav) that promotes both cell cycle exit and cell death was identified. Elevated Cyclin E and Thread/DIAP1 levels are found in mutant cells, resulting in delayed cell cycle exit and impaired apoptosis. Salvador contains two WW domains and binds to the Warts protein kinase. The human ortholog of salvador (hWW45) is mutated in several cancer cell lines. Thus, salvador restricts cell numbers in vivo by functioning as a dual regulator of cell proliferation and apoptosis (Tapon, 2002).
To identify genes that restrict cell growth or cell numbers in vivo, a screen was conducted in the Drosophila eye for mutations that increase the relative representation of mutant tissue compared to wild-type tissue. Using FLP/FRT-induced mitotic recombination, clones of mutant tissue (marked white) were compared in size to sister clones of wild-type tissue (marked red). Those flies were retained whose eyes contained an excess of mutant over wild-type tissue. So far, mutations have been identified in at least 23 distinct loci that elicit this phenotype. These included negative regulators of cell proliferation such as archipelago (ago) as well as homologs of human tumor-suppressor genes including PTEN, TSC1, and TSC2 (Tapon, 2002).
Three alleles of sav were identified. A fourth allele, sav4, was isolated by Jessica Treisman. sav1 and sav2 generate eyes that have an increased representation of mutant tissue (white colored: marked by the expression of a mutant allele of the gene white) over wild-type tissue (red) when compared to the parent chromosome. sav3 elicits a more severe phenotype; in addition to a further increase in the representation of mutant tissue, the mutant tissue protrudes from the eye in folds. sav4 exhibits an intermediate phenotype. Clones of sav3 mutant tissue generated in other parts of the fly including the notum and haltere also display outgrowths. All four alleles are lethal when homozygous, in trans to each other or in trans to the deletion Df(3R)hh that spans the sav locus (Tapon, 2002).
In the eye disc, sav clones contain cells that continue to proliferate for 1224 hr after their normal counterparts stop dividing. Studies of cycling cells show almost no differences between wild-type and mutant populations. However, given that mutant clones contain more ommatidia than wild-type twin spots, accelerated growth must have occurred in mutant tissue anterior to the furrow. Even a relatively minor growth advantage exhibited by mutant cells at every cell cycle can eventually result in increased clone size when amplified by the approximately nine rounds of cell division that occur in the eye primordium prior to the passage of the MF. A subtle change in cell cycle parameters may not easily be detected (Tapon, 2002).
In sav clones, elevated Cyclin E protein levels are observed in the basal nuclei posterior to the MF in the eye imaginal disc. These cells normally stop dividing when they downregulate Cyclin E protein levels. In discs containing many sav clones, the stripe of cyclin E RNA expression is broader and more intense. Thus, the increased level of Cyclin E protein is, at least in part, a result of elevated cyclin E RNA levels. Thus, an inability to downregulate Cyclin E/cdk activity may be the result of increased levels of cyclin E RNA as occurs in sav clones as well as in conditions of impaired protein degradation, or reduced levels of the cdk inhibitor Dacapo. In each case, cell cycle exit is delayed (Tapon, 2002).
Elevated DIAP1 levels are likely to underlie the absence of the developmentally regulated apoptosis in sav clones in the pupal retina as well as the resistance to hid-induced and rpr-induced apoptosis in the larval imaginal disc. The elevated DIAP1 levels appear to result from alterations in posttranscriptional regulation of DIAP1 expression. Recent work has shown that both Rpr and Hid can downregulate DIAP1 levels either by promoting the autoubiquitination of DIAP1 or by causing a generalized inhibition of translation that especially impacts proteins with a short half-life such as DIAP1. Either of these mechanisms is likely to be less efficient in cells that already have elevated levels of DIAP1 (Tapon, 2002).
Sav normally functions to downregulate the basal level of DIAP1 protein. In the absence of Sav, higher levels of DIAP1 accumulate. This increases the level of Hid or Rpr activity that is required to overcome DIAP1-mediated inhibition of caspase activation. Consistent with this model, the more potent form of Hid, Hid-Ala5, is able to partially overcome the increased levels of DIAP1 in sav clones and induce a low level of caspase activity (Tapon, 2002).
Sav appears capable of regulating both cell cycle exit and apoptosis by virtue of its ability to modulate the levels of two key regulators -- Cyclin E and DIAP1. Loss of sav appears to increase cyclin E levels transcriptionally and DIAP1 levels by a posttranscriptional mechansim. Since cell number is determined by both the extent of cell proliferation as well as apoptosis, sav could function as a key regulator of cell number by virtue of its ability to regulate both processes (Tapon, 2002).
One of few pathways that can directly regulate both cell proliferation and cell death is the Ras/MAPK pathway. Ras can promote cell proliferation by promoting growth, and MAP kinase can phosphorylate and inactivate Hid and also reduce Hid transcription. The results indicate that sav might function in a distinct pathway. (1) No change in diphospho-ERK level is observed in sav mutant clones. (2) Cell death induced by the MAP kinase-resistant Hid-Ala5 protein (where five putative MAPK phosphorylation sites have been mutated to alanines) is also reduced by a loss of sav function. However, it is still possible that sav might function downstream of the MAPK family proteins (Tapon, 2002).
Clones of cells mutant for wts generate large tumor-like growths in Drosophila. Wts' human ortholog LATS1 binds to the cdc2 protein kinase in a cell cycle-dependent manner and inhibits its activity. Thus, it has been suggested that excessive Cyclin A/cdc2 may cause excessive cell proliferation by promoting both the G1/S and G2/M transitions. The interaction between wts and cdc2, however, does not explain the excessive and inappropriate growth (mass accumulation) that appears to drive the cell proliferation in clones of wts mutant cells. The defect in cell death in wts cells is also not easily accounted for by the interaction of Wts with cdc2. The data raise the possibility that sav and wts might interact (via a WW domain-PY motif-dependent interaction) and function to promote cell cycle exit and apoptosis during development. However, wts is likely to have sav-independent functions as well. While sav mutations appear to result in a subtle increase in growth rate, the very strong overrepresentation of wts mutant tissue in third instar larval discs indicates that wts mutations must cause a much greater increase in growth rate (Tapon, 2002).
Mice lacking the warts ortholog LATS1 display pituitary hyperplasia and develop slow-growing tumors. This contrasts with the dramatic overgowth phenotype observed in wts mutants in Drosophila. These differences may be due to the presence of other wts homologs (e.g., LATS2) in mammals that can partially compensate for LATS1 inactivation. It is concluded that the strategy of conducting phenotype-based screens in model organisms followed by a search for mutations in cancer cell lines may help identify new tumor suppressor genes (Tapon, 2002).
The sav mutations were localized to the interval 93F11-13 to 94D10-13. High-resolution meiotic mapping localized sav to a 20 kb region that contained five ORFs. All five ORFs were sequenced completely and it was found that all four sav chromosomes had truncating mutations in CG13831. The other four ORFs did not have any amino acid changes. Five independent cDNA clones of CG13831 were examined by restriction mapping, and two independent clones were sequenced completely. The longest clone is 2.2 kb long, which is in agreement with the approximate size of the RNA determined by Northern blotting. The predicted ORF, encoding a protein of 608 amino acids, includes the entire coding region since there is a stop codon upstream and in-frame with the ATG codon. The predicted Sav protein has two WW domains, and its C-terminal portion includes a domain that is likely to adopt the conformation of a coiled-coil. Sav is most similar to the human protein hWW45 (Valverde, 2000) and to the protein encoded by the C. elegans ORF T10H10.3. WW domains are known to mediate protein-protein interactions with various proline-containing motifs. The more C-terminal WW domain lacks the second conserved tryptophan residue that is required for substrate binding and is unlikely to be a functional WW domain. The N-terminal WW domain contains all of the appropriate conserved residues. This putative WW domain is predicted to belong to the Group I family of WW domains that is predicted to interact with the PPXY ('PY') motif (Tapon, 2002).
Since mutations in sav lead to excessive cell proliferation and reduced cell death, tests were performed to see whether hWW45 might be a mutational target in cancer. hWW45 maps to the chromosomal region 14q1314q23 (Valverde, 2000), a locus that is subject to allelic loss in a variety of cancers, including renal cancers, ovarian cancers, and malignant mesothelioma. The entire coding region of hWW45 was sequenced in a panel of 52 tumor-derived cell lines, representing a broad range of tissue types. One colon cancer cell line, HCT15, had a heterozygous C to A mutation at nucleotide 554, resulting in a substitution of aspartic acid for alanine at codon 185. This mutation was not present in 185 population-based controls (370 chromosomes), indicating that it is not a common polymorphism. HCT15 carries a mutation in the mismatch repair gene MSH6, which appears to enhance the frequency of point mutations in other genes. More significantly, two renal cancer cell lines, ACHN and 786-O, were found to have deletions involving hWW45. The normal allele was not present in either cell line, indicating that these cell lines are either homozygous or hemizygous for the deletion. The hWW45 transcript was undetectable by RT-PCR in both cell lines, and a Southern blot using a probe derived from the 3' portion of the gene demonstrated that this part of the gene was absent in both cell lines. In cell line 786-O, PCR analysis of genomic DNA indicated that there is a deletion of ~157 kb with the 5' breakpoint between exons 2 and 3 of hWW45. The deletion in ACHN of ~138 kb encompassed the entire gene. The common region of overlap between these two deletions is only 21 kb, containing exons 35 of hWW45. No other transcription units were identified within this 21 kb interval, using the GENSCAN exon prediction program. Thus, deletions have been identified that would inactivate the human ortholog of sav in at least two cancer cell lines (Tapon, 2002).
Originally identified in Drosophila, the Warts(Wts)/Lats protein kinase has been proposed to function with two other Drosophila proteins, Hippo (Hpo) and Salvador (Sav), in the regulation of cell cycle exit and apoptosis. In mammals, two candidate Warts/Lats homologs, termed Lats1 and Lats2, have been described, and the targeted disruption of LATS1 in mice increases tumor formation. Little, however, is known about the function and regulation of human Lats kinases. Human Mst2, a STE20-family member and purported Hpo ortholog, phosphorylates and activates both Lats1 and Lats2. Deletion analysis reveals that regulation of Lats1 occurs through the C-terminal, catalytic domain. Within this domain, two regulatory phosphorylation sites were identified by mass spectrometry. These sites, S909 in the activation loop and T1079 within a hydrophobic motif, have been highly conserved during evolution. Moreover, a direct interaction is observed between Mst2 and hWW45, a putative ortholog of Drosophila Sav. These results indicate that Mst2-like kinases regulate Lats kinase activities in an evolutionarily conserved regulatory pathway. Although the function of this pathway remains poorly understood in mammals, it is intriguing that, in Drosophila, it has been linked to development and tissue homeostasis ( Chan, 2005 ).
date revised: 1 September 2002
Home page: The Interactive Fly © 1995, 1996 Thomas B. Brody, Ph.D.
The Interactive Fly resides on the
Society for Developmental Biology's Web server.